查看“BrickerHoule352”的源代码

Since it was unearthed that the risks of hormone treatment outweighed the benefits, experts have now been trying to find a safe, natural method to relieve the symptoms of menopause. 

Individuals are currently being employed for a clinical trial of remedy referred to as MF101 produced by Bionovo, Inc. In its initial clinical trial, MF101 provided women in the analysis with preliminary evidence of relief from such signs as hot flashes and night sweats, minus the risks associated with hormone therapy. 

The treatment being tested clinically targets just one of the two identified estrogen receptors-the estrogen receptor beta. Lab data shows that MF101 does not cause the growth of breast or uterine cancer cells the way hormone therapy can, making the drug a safer option to currently available hormone treatments. 

In 2002, the Women's Health Initiative (WHI) Estrogen Plus Progestin Trial, with over 16,000 women participants, was stopped early when it was found that the standard measure of mixture hormone therapy increased the chance of breast cancer, stroke, center attacks, blood clots and dementia. 

"Given the void that exists for a and effective therapy for menopausal symptoms, our purpose is always to discover and develop novel drugs such as MF101 that may abate many of the symptoms that have historically been handled with hormones," said Dr. Mary Tagliaferri. Tagliaferri is co-author of "The New Menopause Book: The Experts Assist You To Make Educated Decisions on HRT, Normal Hormone Treatment, Herbal Therapies, Old-fashioned Chinese Medicine And More" (Avery, 2006) and Chief Medical Officer of Bionovo, which can be developing the drug. 

The clinical trials can take place under the directorship of renowned researcher Dr. Deborah Grady at four leading academic medical centers. 

This Phase 2 trial is expected by bionovo to be accomplished by the second quarter of 2007. 

"If this new medicine proves to be effective, we are providing health care practitioners with a treatment they could comfortably recommend to females encountering menopause," said Dr. Tagliaferri. [http://growthhormonezone.com/ advertisers]